Climb Bio, Inc. (CLYM)
NASDAQ: CLYM · Real-Time Price · USD
1.270
-0.030 (-2.31%)
Apr 25, 2025, 4:00 PM EDT - Market closed

Climb Bio Statistics

Total Valuation

Climb Bio has a market cap or net worth of $85.69 million. The enterprise value is -$126.30 million.

Market Cap 85.69M
Enterprise Value -126.30M

Important Dates

The next estimated earnings date is Wednesday, May 14, 2025, before market open.

Earnings Date May 14, 2025
Ex-Dividend Date n/a

Share Statistics

Climb Bio has 67.48 million shares outstanding. The number of shares has increased by 78.47% in one year.

Current Share Class 67.48M
Shares Outstanding 67.48M
Shares Change (YoY) +78.47%
Shares Change (QoQ) -3.40%
Owned by Insiders (%) 0.60%
Owned by Institutions (%) 41.24%
Float 30.64M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.40
P/TBV Ratio 0.40
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 31.41, with a Debt / Equity ratio of 0.00.

Current Ratio 31.41
Quick Ratio 30.83
Debt / Equity 0.00
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -46.26% and return on invested capital (ROIC) is -10.54%.

Return on Equity (ROE) -46.26%
Return on Assets (ROA) -10.30%
Return on Invested Capital (ROIC) -10.54%
Return on Capital Employed (ROCE) -12.72%
Revenue Per Employee n/a
Profits Per Employee -$4.11M
Employee Count 18
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -65.85% in the last 52 weeks. The beta is -0.10, so Climb Bio's price volatility has been lower than the market average.

Beta (5Y) -0.10
52-Week Price Change -65.85%
50-Day Moving Average 1.33
200-Day Moving Average 3.82
Relative Strength Index (RSI) 48.27
Average Volume (20 Days) 164,911

Short Selling Information

The latest short interest is 2.30 million, so 3.41% of the outstanding shares have been sold short.

Short Interest 2.30M
Short Previous Month 2.20M
Short % of Shares Out 3.41%
Short % of Float 7.51%
Short Ratio (days to cover) n/a

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -27.00M
Pretax Income n/a
Net Income -73.90M
EBITDA n/a
EBIT -27.00M
Earnings Per Share (EPS) -$1.53
Full Income Statement

Balance Sheet

The company has $150.92 million in cash and $532,000 in debt, giving a net cash position of $212.00 million or $3.14 per share.

Cash & Cash Equivalents 150.92M
Total Debt 532,000
Net Cash 212.00M
Net Cash Per Share $3.14
Equity (Book Value) 211.88M
Book Value Per Share 3.15
Working Capital 149.94M
Full Balance Sheet

Cash Flow

Operating Cash Flow -15.56M
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Climb Bio does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -78.47%
Shareholder Yield n/a
Earnings Yield -86.23%
FCF Yield n/a

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1